Share
Innovation continues to generate significant impact across multiple sectors. Microalgae and marine microorganisms are rapidly moving beyond their traditional role as mere subjects of ecological research, establishing themselves as strategic technological platforms in health, nutrition, energy and aquaculture. Recent advances demonstrate their potential as biofactories for sustainable oils, as intelligent platforms for targeted probiotic delivery, and as sources of functional ingredients. These developments position marine biotechnology as one of the pillars of the next generation of sustainable solutions.
This invention discloses a high-protein microbial biomass–based feed for fish, crustaceans, and/or cephalopods, comprising bacterial biomass, its extract, or its hydrolysate, containing at least 25% (w/w) protein and at least 5% (w/w) nucleic acids on a dry matter basis. The composition promotes enhanced growth performance and improves resistance to infectious diseases in marine organisms, making it particularly suitable for aquaculture applications.
Patentscope
Discover more here.
Salmon Feed Production Using Schizochytrium sp. Biomass
A feed composition comprising microalgae-derived biomass, according to the present application, uses microalgae with a high content of protein, fat, and minerals, and free from factors that degrade feed quality, and can thus be effectively used as a fish feed composition
Patentscope
Discover more here
Probiotic-Loaded Microalgae Robots for Inflammatory Bowel Disease Management
Inflammatory bowel disease (IBD) is characterized by elevated intestinal ROS and microbial imbalance. We developed the EcN@PDA@HP biohybrid robot, which combines stress-trained microalgae (Haematococcus pluvialis) with polydopamine-coated probiotics and an intestinal braking system. Stress-trained microalgae withstand gastric conditions, retain motility, and produce enhanced levels of astaxanthin. The PDA coating protects probiotics and facilitates adhesion to inflamed sites. The EcN@PDA@HP biohybrid robot alleviates IBD by scavenging ROS and restoring gut microbiota.
PMC
Discover more here.
RNA Extraction and rRNA Depletion Methods for RNA-Seq in Edible Seaweeds
Seaweeds are valuable for food, pharmaceutical, and cosmetic applications, but genomic studies are limited by challenges in RNA extraction and rRNA depletion. This study evaluated seven RNA extraction protocols across 11 edible seaweed species (brown, red, and green), finding that CTAB-based methods are best for brown algae, while spin-column methods perform better for red and green algae. Three commercial rRNA depletion kits were tested, with RiboFree and riboPOOL outperforming Ribo-Zero Plant. These results provide practical guidance for RNA-seq preparation across different seaweed taxa.
PMC
Discover more here.
Microalgae as a Sustainable Alternative to Palm Oil: Fatty Acid Profiles
Microalgae are being investigated as a sustainable alternative to palm oil because of their capacity to produce fatty acids (FAs). Ten strains were evaluated under photoautotrophic and heterotrophic growth conditions, with 400 µmol photons m⁻² s⁻¹ identified as the optimal light intensity for biomass production and total fatty acid (TFA) accumulation. Species of Scenedesmus and Desmodesmus exhibited the highest growth performance, with S. obliquus and D. subspicatus achieving up to 66% and 58% TFA of dry weight, respectively. The fatty acid profile of D. subspicatus (palmitic acid 39%, oleic acid 30%, linoleic acid 14%) was the most similar to that of palm oil, whereas heterotrophic cultivation proved less effective.
PMC
Discover more here.
Microalgal Extracellular Vesicles for Vaccines and Immunomodulation
Microalgal extracellular vesicles (MEVs) carrying bioactive cargo, including antigens, proteins, and nucleic acids, are utilized in vaccines and immunomodulatory therapies. MEVs can be administered via multiple routes to modulate the immune system. These vaccines may exert therapeutic, immunoprotective, or immunomodulatory effects. The compositions may also target intracellular receptors to enhance immune responses
Patentscope
Discover more here.
+351 220 731 375
b2e@b2e.pt
Avenida da Liberdade, s/n, sala E7
4450-718 Leça da Palmeira